Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Vaginal infections are common, frequently recur, and may increase women's risk for sexually transmitted infections (STIs). We tested the efficacy of a novel regimen to prevent recurrent vaginal infections. METHODS: Human immunodeficiency virus (HIV)-negative women 18-45 years old with 1 or more vaginal infections, including bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), or Trichomonas vaginalis (TV), were randomly assigned to receive vaginal suppositories containing metronidazole 750 mg plus miconazole 200 mg or matching placebo for 5 consecutive nights each month for 12 months. Primary endpoints, evaluated every 2 months, were BV (Gram stain) and VVC (positive wet mount and culture). RESULTS: Participants (N = 234) were randomly assigned to the intervention (N = 118) or placebo (N = 116) arm. Two hundred seventeen (93%) women completed an end-of-study evaluation. The intervention reduced the proportion of visits with BV compared to placebo (21.2% vs 32.5%; relative risk [RR] 0.65, 95% confidence interval [CI] .48-.87). In contrast, the proportion of visits with VVC was similar in the intervention (10.4%) versus placebo (11.3%) arms (RR 0.92, 95% CI .62-1.37). CONCLUSIONS: Monthly treatment with intravaginal metronidazole plus miconazole reduced the proportion of visits with BV during 12 months of follow-up. Further study will be important to determine whether this intervention can reduce women's risk of STIs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
Sobel, J. D., Wiesenfeld, H. C., Martens, M., Danna, P., Hooton, T. M., Rompalo, A., Sperling, M., Livengood, C., Horowitz, B., Von Thron, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033114 · Cited by 487
Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis
Cherpes, T. L., Meyn, L. A., Krohn, M. A., Lurie, J. G., & Hillier, S. L. (2003) · Clinical Infectious Diseases · doi:10.1086/375819 · Cited by 415 · cited 1×
“Bacterial vaginosis has also been associated with herpes simplex virus type-2 (HSV-2) [10–12], human papilloma virus (HPV) [13], Neisseria gonorrhoeae [14], Chlamydia trachomatis [14, 15], and TV [8, 15–17].”
BackgroundBacterial Vaginosis and the Risk of Trichomonas vaginalis Acquisition Among HIV-1–Negative Women
Balkus, J. E., Richardson, B. A., Rabe, L. K., Taha, T. E., Mgodi, N., Kasaro, M. P., Ramjee, G., Hoffman, I. F., & Abdool Karim, S. S. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000075 · Cited by 89
Self-citation
Cited by
Sexually transmitted infections: challenges ahead
Unemo, M., Bradshaw, C. S., Hocking, J. S., de Vries, H. J. C., Francis, S. C., Mabey, D., Marrazzo, J. M., Sonder, G. J. B., Schwebke, J. R., Hoornenborg, E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30310-9 · Cited by 751
Self-citationRandomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis
Cohen, C. R., Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915254 · Cited by 377
Sherrard, J., Wilson, J., Donders, G., Mendling, W., & Jensen, J. S. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418785451 · Cited by 297
Current Treatment of Bacterial Vaginosis—Limitations and Need for Innovation
Bradshaw, C. S., & Sobel, J. D. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw159 · Cited by 245
Masese, L., Baeten, J. M., Richardson, B. A., Bukusi, E., John-Stewart, G., Graham, S. M., Shafi, J., Kiarie, J., Overbaugh, J., & McClelland, R. S. (2015) · AIDS · doi:10.1097/qad.0000000000000646 · Cited by 70
Self-citation
Metadata
- Authors
- McClelland, R. S., Balkus, J. E., Lee, J., Anzala, O., Kimani, J., Schwebke, J., Bragg, V., Lensing, S., & Kavak, L.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-12-19
- Volume
- 211
- Issue
- 12
- Pages
- 1875-1882
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2135769723
- Cited by
- 49
- References
- 3
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women. https://app.cochat.ai/papers/10.1093/infdis/jiu818
- The paper
- McClelland, R. S., Balkus, J. E., Lee, J., Anzala, O., Kimani, J., Schwebke, J., Bragg, V., Lensing, S., & Kavak, L. (2015). Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiu818
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.